This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Kalantzis N, Gabriel P, Mouzas J, et al Acute amiodarone-induced hepatitis. Hepatogastroenterology. 1991;38:71-4.KalantzisNGabrielPMouzasJet alAcute amiodarone-induced hepatitisHepatogastroenterology199138714Search in Google Scholar
Giannatasio F, Salvio A, Varriale M, et al Three cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicity. Ann Ital Med Int. 2002;17:180-4.GiannatasioFSalvioAVarrialeMet alThree cases of severe acute hepatitis after parenteral administration of amiodarone: the active ingredient is not the only agent responsible for hepatotoxicityAnn Ital Med Int2002171804Search in Google Scholar
MacFadyen RJ, Palmer TJ, Hisamuddin K. Rapidly fatal acute amiodarone hepatitis occurring in the context of multiple organ failure. Int J Cardiol. 2003:91;245-7.MacFadyenRJPalmerTJHisamuddinKRapidly fatal acute amiodarone hepatitis occurring in the context of multiple organ failureInt J Cardiol200391245710.1016/S0167-5273(02)00613-7Search in Google Scholar
Gayam V, Khalid M, Dahal S, et al Fatal Acute Liver Failure With Intravenous Amiodarone: A Case Report and Literature Review. Gastroenterology Res. 2018;11:62-3.GayamVKhalidMDahalSet alFatal Acute Liver Failure With Intravenous Amiodarone: A Case Report and Literature ReviewGastroenterology Res20181162310.14740/gr911wSearch in Google Scholar
Gluck N, Fried M, Porat R. Acute Isr Med Assoc J. 2011;13:748-052.GluckNFriedMPoratRAcute Isr Med Assoc J201113748052Search in Google Scholar
Li JG, Yang TC, Yu DM, Ren TH. Fatal acute liver failure after intravenous amiodarone administration. J Formos Med Assoc. 2015;114:294-6.LiJGYangTCYuDMRenTHFatal acute liver failure after intravenous amiodarone administrationJ Formos Med Assoc2015114294610.1016/j.jfma.2013.07.011Search in Google Scholar
Verhovez A, Elia F, Riva A, Ferrari G, Aprà A. Acute liver injury after intravenous amiodarone: a case report. Am J Emerg Med. 2011;29:843.e5-6.VerhovezAEliaFRivaAFerrariGAprà A. Acute liver injury after intravenous amiodarone: a case reportAm J Emerg Med201129843e5-610.1016/j.ajem.2010.03.035Search in Google Scholar
Fromenty B, Fisch C, Labbe G, et al Amiodarone inhibits the mitochondrial beta-oxidation of faty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther. 1990;255:1371-6.FromentyBFischCLabbeGet alAmiodarone inhibits the mitochondrial beta-oxidation of faty acids and produces microvesicular steatosis of the liver in miceJ Pharmacol Exp Ther199025513716Search in Google Scholar
Lewis JH, Mullick F, Ishak KG, et al Histopathologic analysis of suspected amiodarone toxicity. Human Pathol. 1990;21:59-67.LewisJHMullickFIshakKGet alHistopathologic analysis of suspected amiodarone toxicityHuman Pathol199021596710.1016/0046-8177(90)90076-HSearch in Google Scholar
Rätz Bravo AE, Drewe J, Schlienger RG, et al Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature. Critical Care Med. 2005;33:128-34; discussion 245-6.RätzBravo AEDreweJSchliengerRGet alHepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literatureCritical Care Med20053312834discussion 245-610.1097/01.CCM.0000151048.72393.44Search in Google Scholar
Tsuda T, Tada H, Tanaka Y, et al Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports. J Med Case Rep. 2018;12:95.TsudaTTadaHTanakaYet alAmiodarone-induced reversible and irreversible hepatotoxicity: two case reportsJ Med Case Rep2018129510.1186/s13256-018-1629-8589939529653592Search in Google Scholar
Chan AL, Hsieh HJ, Hsieh YA, Lin SJ. Fatal amiodarone-induced hepatotoxicity: A case report and literature review. Int J Clin Pharmacol Ther. 2008;46:96-101.ChanALHsiehHJHsiehYALinSJFatal amiodarone-induced hepatotoxicity: A case report and literature reviewInt J Clin Pharmacol Ther2008469610110.5414/CPP46096Search in Google Scholar
Hashmi A, Keswani NR, Kim S, Graham DY. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. South Med J. 2016;109:83-6.HashmiAKeswaniNRKimSGrahamDYHepatic Dysfunction in Patients Receiving Intravenous AmiodaroneSouth Med J201610983610.14423/SMJ.0000000000000413474355026840961Search in Google Scholar
Diab OA, Kamel J, Abd-Elhamid AA. Predictors of intravenous amiodarone induced liver injury. Egypt Heart J. 2017;69:45-54.DiabOAKamelJAbd-ElhamidAAPredictors of intravenous amiodarone induced liver injuryEgypt Heart J201769455410.1016/j.ehj.2016.05.001583936529622954Search in Google Scholar
Chen CC, Wu CC. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature. Am J Ther. 2016;23, e260-3.ChenCCWuCCAcute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the LiteratureAm J Ther201623e260310.1097/MJT.0000000000000149Search in Google Scholar
Hoofnagle JH, Björnsson ES. Drug-Induced Liver Injury - Types and Phenotypes. N Engl J Med. 2019;381:264-73.HoofnagleJHBjörnssonESDrug-Induced Liver Injury - Types and PhenotypesN Engl J Med20193812647310.1056/NEJMra1816149Search in Google Scholar
Begriche K, Massart J, Robin MA, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol. 2011;54:773-94.BegricheKMassartJRobinMABorgne-SanchezAFromentyBDrug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liverJ Hepatol2011547739410.1016/j.jhep.2010.11.006Search in Google Scholar
Spaniol M, Bracher R, Ha HR, Follath F, Krähenbühl S. Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J Hepatol. 2001;35:628-36.SpaniolMBracherRHaHRFollathFKrähenbühlSToxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondriaJ Hepatol2001356283610.1016/S0168-8278(01)00189-1Search in Google Scholar
Fromenty B, Fisch C, Berson A, et al Dual efect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling efect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther. 1990;255:1377-84.FromentyBFischCBersonAet alDual efect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling efect followed by inhibition of the respiratory chain at the levels of complex I and complex IIJ Pharmacol Exp Ther1990255137784Search in Google Scholar
Kennedy JA, Unger SA, Horowitz JD. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem Pharmacol. 199;52:273-80.KennedyJAUngerSAHorowitzJDInhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodaroneBiochem Pharmacol199522738010.1016/0006-2952(96)00204-3Search in Google Scholar
Felser A, Blum K, Lindinger PW, Bouitbir J, Krähenbühl S. Mechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodarone. Toxicol Sci. 2013;131:480-90.FelserABlumKLindingerPWBouitbirJKrähenbühlSMechanisms of hepatocellular toxicity associated with dronedarone--a comparison to amiodaroneToxicol Sci20131314809010.1093/toxsci/kfs29823135547Search in Google Scholar
Massart J, Begriche K, Buron N, et al Drug-induced inhibition of mitochondrial faty acid oxidation and steatosis. Curr Pathobiol Rep. 2013;1:147-57.MassartJBegricheKBuronNet alDrug-induced inhibition of mitochondrial faty acid oxidation and steatosisCurr Pathobiol Rep201311475710.1007/s40139-013-0022-ySearch in Google Scholar
Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila). 2009;47:101-11.LheureuxPEHantsonPCarnitine in the treatment of valproic acid-induced toxicityClin Toxicol (Phila)2009471011110.1080/1556365090275237619280426Search in Google Scholar
Begriche K, Massart J, Robin MA, et al Mitochondrial adaptations and dysfunctions in nonalcoholic faty liver disease. Hepatology. 2013;58:1497-507.BegricheKMassartJRobinMAet alMitochondrial adaptations and dysfunctions in nonalcoholic faty liver diseaseHepatology201358149750710.1002/hep.2622623299992Search in Google Scholar
Massart J, Begriche K, Moreau C, et al Role of nonalcoholic faty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res. 2017;3(Suppl 1):212-32.MassartJBegricheKMoreauCet alRole of nonalcoholic faty liver disease as risk factor for drug-induced hepatotoxicityJ Clin Transl Res20173Suppl 121232Search in Google Scholar
Matar W, Juliar B, Gradus-Pizlo I, et al Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure. J Gastrointestin Liver Dis. 2009;18:419-23.MatarWJuliarBGradus-PizloIet alAmiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failureJ Gastrointestin Liver Dis20091841923Search in Google Scholar
